Beskrivelse
Krav
IPC-klasse
Avsender
Org.nummer: 979993269
Statushistorie for 2021/02023
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Avgjort | Forespørsel tatt til følge |
Under behandling | Mottatt |
Korrespondanse for 2021/02023
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
GH Forespørsel
|
Innkommende
Generell henvendelse
|
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2012.02.29, US 201261605117 P
STANGEL M: "[Transplantation of myelinating cells as regenerative therapy for multiple sclerosis: Experimental basis and present state of clinical studies.]", NERVENARZT, vol. 73, no. 10, 2002, pages 937-945, XP002706322, ISSN: 0028-2804 (B1)
SEKIGUCHI K ET AL: "P12-11 Nerve conduction characteristics of infliximab induced demyelinating neuropathy", CLINICAL NEUROPHYSIOLOGY, ELSEVIER SCIENCE, IE, vol. 121, 1 October 2010 (2010-10-01), page S174, XP027454864, ISSN: 1388-2457, DOI: 10.1016/S1388-2457(10)60715-8 [retrieved on 2010-10-01] (B1)
VARGAS MAURICIO E ET AL: "Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 107, no. 26, June 2010 (2010-06), pages 11993-11998, XP002695282, ISSN: 0027-8424 cited in the application (B1)
VERMA A ET AL: "High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy", NEUROLOGY, vol. 44, no. 2, 1994, pages 248-250, XP008163795, ISSN: 0028-3878 (B1)
WARRINGTON A E ET AL: "HUMAN MONOCLONAL ANTIBODIES REACTIVE TO OLIGODENDROCYTES PROMOTE REMYELINATION IN A MODEL OF MULTIPLE SCLEROSIS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 97, no. 12, 6 June 2000 (2000-06-06), pages 6820-6825, XP000941806, ISSN: 0027-8424, DOI: 10.1073/PNAS.97.12.6820 (B1)
ZHANG J ET AL: "A model for ex vivo spinal cord segment culture-A tool for analysis of injury repair strategies", JOURNAL OF NEUROSCIENCE METHODS, ELSEVIER SCIENCE PUBLISHER B.V., AMSTERDAM, NL, vol. 192, no. 1, 30 September 2010 (2010-09-30), pages 49-57, XP027258913, ISSN: 0165-0270 [retrieved on 2010-09-01] (B1)
ZOCHODNE D W ET AL: "Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy", ACTA NEUROLOGICA SCANDINAVICA 20030401 GB, vol. 107, no. 4, 1 April 2003 (2003-04-01) , pages 299-301, XP002695283, ISSN: 0001-6314 (B1)
COLOVER J: "Polyneuropathy in type 2 diabetes mellitus", THE LANCET, LANCET LIMITED. LONDON, GB, vol. 358, no. 9298, 15 December 2001 (2001-12-15), page 2086, XP004805732, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(01)07124-0 (B1)
ENGLAND J D ET AL: "Peripheral neuropathy", THE LANCET, LANCET LIMITED. LONDON, GB, vol. 363, no. 9427, 26 June 2004 (2004-06-26), pages 2151-2161, XP004778376, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(04)16508-2 (B1)
F. R. Fricker ET AL: "Axonally Derived Neuregulin-1 Is Required for Remyelination and Regeneration after Nerve Injury in Adulthood", THE JOURNAL OF NEUROSCIENCE, vol. 31, no. 9, 2 March 2011 (2011-03-02), pages 3225-3233, XP055540718, US ISSN: 0270-6474, DOI: 10.1523/JNEUROSCI.2568-10.2011 (B1)
HONMOU O ET AL: "RESTORATION OF NORMAL CONDUCTION PROPERTIES IN DEMYELINATED SPINAL CORD AXONS IN THE ADULT RAT BY TRANSPLANTATION OF EXOGENOUS SCHWANNCELLS", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 16, no. 10, 15 May 1996 (1996-05-15), pages 3199-3208, XP002945997, ISSN: 0270-6474 (B1)
JOERG-PATRICK STÃ 1/4 BGEN: "Drug-induced dysimmune demyelinating neuropathies", JOURNAL OF NEUROLOGICAL SCIENCES, ELSEVIER SCIENTIFIC PUBLISHING CO, AMSTERDAM, NL, vol. 307, no. 1, 11 May 2011 (2011-05-11), pages 1-8, XP028234970, ISSN: 0022-510X, DOI: 10.1016/J.JNS.2011.05.010 [retrieved on 2011-05-17] (B1)
K. R. JESSEN ET AL: "The repair Schwann cell and its function in regenerating nerves : Repair Schwann cell and its function in regenerating nerves", THE JOURNAL OF PHYSIOLOGY, vol. 594, no. 13, 1 July 2016 (2016-07-01) , pages 3521-3531, XP055540720, GB ISSN: 0022-3751, DOI: 10.1113/JP270874 (B1)
KRENDEL D A ET AL: "Successful treatment of neuropathies in patients with diabetes mellitus", ARCHIVES OF NEUROLOGY 1995 US, vol. 52, no. 11, 1995, pages 1053-1061, XP008161377, ISSN: 0003-9942 (B1)
KUHLMANN TANJA ET AL: "Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins", JOURNAL OF NEUROSCIENCE RESEARCH, vol. 67, no. 2, 15 January 2002 (2002-01-15), pages 185-190, XP002706323, ISSN: 0360-4012 (B1)
Kristján R. Jessen ET AL: "Negative regulation of myelination: Relevance for development, injury, and demyelinating disease", Glia, vol. 56, no. 14, 1 November 2008 (2008-11-01), pages 1552-1565, XP055540722, ISSN: 0894-1491, DOI: 10.1002/glia.20761 (B1)
Latov et al: "Immunological and infectious diseases of the peripheral nerves", 28 May 1998 (1998-05-28), XP002706321, ISBN: 0521462657 page 340, page 340, last paragraph before the new § "sequence of events" (B1)
Maria Carolina O. Rodrigues ET AL: "Peripheral Nerve Repair with Cultured Schwann Cells: Getting Closer to the Clinics", THE SCIENTIFIC WORLD JOURNAL, vol. 2012, 1 January 2012 (2012-01-01), pages 1-10, XP055364905, GB, NL ISSN: 1537-744X, DOI: 10.1100/2012/413091 (B1)
NOTGHI L M ET AL: "P12-12 Neonatal axonal neuropathy: a curious presentation of congenital hypomyelination", CLINICAL NEUROPHYSIOLOGY, ELSEVIER SCIENCE, IE, vol. 121, 1 October 2010 (2010-10-01), pages S174-S175, XP027454865, ISSN: 1388-2457, DOI: 10.1016/S1388-2457(10)60716-X [retrieved on 2010-10-01] (B1)
ODAKA M ET AL: "Treatment response to steroid and intravenous immunoglobulin in a patient with chronic sensory demyelinating neuropathy", JOURNAL OF CLINICAL NEUROMUSCULAR DISEASE 200706 US, vol. 8, no. 4, June 2007 (2007-06), pages 207-211, XP002695284, ISSN: 1522-0443 (B1)
P. Y. K. Van Den Bergh ET AL: "European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher : EFNS/PNS CIDP guideline - first revision", EUROPEAN JOURNAL OF NEUROLOGY, vol. 17, no. 3, 1 March 2010 (2010-03-01), pages 356-363, XP055450077, GB ISSN: 1351-5101, DOI: 10.1111/j.1468-1331.2009.02930.x (B1)
VAN SCHAIK I N ET AL: "Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies?", MULTIPLE SCLEROSIS, SAGE PUBLICATIONS, BASINGSTOKE, GB, vol. 3, no. 2, 1 April 1997 (1997-04-01), pages 98-104, XP008161364, ISSN: 1352-4585, DOI: 10.1177/135245859700300208 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2820042)
|
Utgående
EP Registreringsbrev (3210) (PTEP2820042)
|
Innkommende, AR339947215
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 13. avg. år (EP) | 2025.01.23 | 5460 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2024.01.25 | 3850 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2023.01.20 | 3500 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2022.01.21 | 3200 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2021.01.22 | 2850 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2020.01.27 | 2550 | ANAQUA SERVICES SAS | Betalt og godkjent |
31917388 expand_more expand_less | 2019.10.30 | 5500 | BRYN AARFLOT AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|